| Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study A Varatharaj, N Thomas, MA Ellul, NWS Davies, TA Pollak, EL Tenorio, ... The Lancet Psychiatry 7 (10), 875-882, 2020 | 1615 | 2020 |
| Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke RL Sacco, HC Diener, S Yusuf, D Cotton, S Ôunpuu, WA Lawton, ... New England Journal of Medicine 359 (12), 1238-1251, 2008 | 1306 | 2008 |
| Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) KL Woods, S Fletcher, CH Roffe, Y Haider The Lancet 339 (8809), 1553-1558, 1992 | 758 | 1992 |
| Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke CS Anderson, T Robinson, RI Lindley, H Arima, PM Lavados, TH Lee, ... New England Journal of Medicine 374 (24), 2313-2323, 2016 | 542 | 2016 |
| Post-stroke dysphagia: a review and design considerations for future trials DL Cohen, C Roffe, J Beavan, B Blackett, CA Fairfield, S Hamdy, ... International Journal of Stroke 11 (4), 399-411, 2016 | 524 | 2016 |
| Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial N Sprigg, K Flaherty, JP Appleton, RAS Salman, D Bereczki, M Beridze, ... The Lancet 391 (10135), 2107-2115, 2018 | 483 | 2018 |
| Diagnosis of stroke-associated pneumonia CJ Smith, AK Kishore, A Vail, A Chamorro, J Garau, SJ Hopkins, ... Stroke, 2015 | 469 | 2015 |
| Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data L San Román, BK Menon, J Blasco, M Hernández-Pérez, A Dávalos, ... The Lancet Neurology 17 (10), 895-904, 2018 | 383 | 2018 |
| Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis … BCV Campbell, CBLM Majoie, GW Albers, BK Menon, N Yassi, G Sharma, ... The Lancet Neurology 18 (1), 46-55, 2019 | 364 | 2019 |
| Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial M Dennis, G Mead, J Forbes, C Graham, M Hackett, GJ Hankey, A House, ... The Lancet 393 (10168), 265-274, 2019 | 303 | 2019 |
| Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint … CS Anderson, Y Huang, RI Lindley, X Chen, H Arima, G Chen, Q Li, ... The Lancet 393 (10174), 877-888, 2019 | 266 | 2019 |
| Cerebral microbleeds and intracranial haemorrhage risk in patients anticoagulated for atrial fibrillation after acute ischaemic stroke or transient ischaemic attack (CROMIS-2 … D Wilson, G Ambler, C Shakeshaft, MM Brown, A Charidimou, ... The Lancet Neurology 17 (6), 539-547, 2018 | 261 | 2018 |
| e-ASPECTS software is non-inferior to neuroradiologists in applying the ASPECT score to computed tomography scans of acute ischemic stroke patients S Nagel, D Sinha, D Day, W Reith, R Chapot, P Papanagiotou, ... International Journal of Stroke 12 (6), 615-622, 2017 | 236 | 2017 |
| British Thoracic Society Guideline for oxygen use in adults in healthcare and emergency settings BR O'Driscoll, LS Howard, J Earis, V Mak, S Bajwah, R Beasley, K Curtis, ... BMJ open respiratory research 4 (1), 2017 | 216 | 2017 |
| Effect of routine low-dose oxygen supplementation on death and disability in adults with acute stroke: the stroke oxygen study randomized clinical trial C Roffe, T Nevatte, J Sim, J Bishop, N Ives, P Ferdinand, R Gray, ... Jama 318 (12), 1125-1135, 2017 | 207 | 2017 |
| Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial RAS Salman, MS Dennis, PAG Sandercock, CLM Sudlow, JM Wardlaw, ... The Lancet 393 (10191), 2613-2623, 2019 | 200 | 2019 |
| Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study RJ Perry, A Tamborska, B Singh, B Craven, R Marigold, P Arthur-Farraj, ... The Lancet 398 (10306), 1147-1156, 2021 | 196 | 2021 |
| Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial SE Kasner, B Swaminathan, P Lavados, M Sharma, K Muir, R Veltkamp, ... The Lancet Neurology 17 (12), 1053-1060, 2018 | 195 | 2018 |
| Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a … PM Bath, LJ Woodhouse, JP Appleton, M Beridze, H Christensen, ... The Lancet 391 (10123), 850-859, 2018 | 191 | 2018 |
| Cerebral microbleeds and stroke risk after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies D Wilson, G Ambler, KJ Lee, JS Lim, M Shiozawa, M Koga, L Li, ... The Lancet Neurology 18 (7), 653-665, 2019 | 190 | 2019 |
Philip BathStroke Association Professor of Stroke Medicine, University of NottinghamAdresă de e-mail confirmată pe nottingham.ac.uk
